Chabner Colloquium 2017

Abstract Book

Session 1:
New Insights into DNA Repair and Drug Response

Targeting the ATR Kinase in Cancer Therapy
Lee Zou, PhD
Lecture: Audio|Slides

PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian Cancer
Alan D’Andrea, MD

Assessing DNA Repair in Clinical Trials
Ted Hong, MD
Lecture: Audio|Slides

Session 2:
Targets That Defy Effective Therapy

Developing Therapies for Ras-driven>
CancersKaren Cichowski, PhD
Lecture: Audio|Slides

Is FGFR Inhibition an Effective Target in Gastrointestinal Tumors?
Lipika Goyal, MD
Lecture: Audio|Slides

Intergenic Fusions in Advanced HR+ Breast Cancer

Leif Ellisen, MD, PhD

Lecture: Audio|Slides

Session 3:
Promising Drug-antibody Conjugates and Cell Death Pathway Inhibitors

Genomic and Functional Characterization of Patient Derived Xenograft Models of Small Cell Lung Cancer
Anna Farago, MD, PhD
Lecture: Audio|Slides

Antibody Drug Conjugates for Triple Negative Breast Cancer: Targeting Positive in the Negative
Aditya Bardia, MD, MPH
Lecture: Audio|Slides

PARP in Breast Cancer
Steven J. Isakoff, MD, PhD
Lecture:Audio|Slides

Session 4:
Junior Faculty Forum

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor
Spheroids
Russell Jenkins, MD, PhD
Lecture: Audio|Slides 
Financial Toxicity of Cancer
Ryan Nipp, MD, MPH
Lecture: Audio|Slides 
Improving Therapy for EGFR-Mutant Lung Cancers
Zosia Piotrowska, MD
Lecture: Audio|Slides 
2017 Acknowledgments

The Society for Translational Oncology gratefully acknowledges educational grants in partial support of this activity from:

Amgen
EcoR1 Capital
Lilly
Novartis
Pfizer